gastroenteritis Clinical Trials

10 recruitingLast updated: May 21, 2026

There are 10 actively recruiting gastroenteritis clinical trials across 6 countries. Studies span Phase 2, Not Applicable, Phase 1, Phase 4. Top locations include Philadelphia, Pennsylvania, United States, Phoenix, Arizona, United States, Cincinnati, Ohio, United States. Updated daily from ClinicalTrials.gov.


gastroenteritis Trials at a Glance

10 actively recruiting trials for gastroenteritis are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 2 with 2 trials, with the heaviest enrollment activity in Philadelphia, Phoenix, and Cincinnati. Lead sponsors running gastroenteritis studies include Assiut University, Association Clinique Thérapeutique Infantile du val de Marne, and Ann & Robert H Lurie Children's Hospital of Chicago.

Browse gastroenteritis trials by phase

About gastroenteritis Clinical Trials

Looking for clinical trials for gastroenteritis? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new gastroenteritis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about gastroenteritis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 110 of 10 trials

Recruiting
Phase 4

Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea

gastroenteritisDiarrheaBacterial infection
Bausch Health Americas, Inc.54 enrolled5 locationsNCT07285785
Recruiting

Eosinophilic Gastrointestinal Disorders Registry

eosinophilic esophagitisEosinophilic GastroenteritisEosinophilic Colitis+1 more
Ann & Robert H Lurie Children's Hospital of Chicago500 enrolled1 locationNCT05199532
Recruiting
Phase 1Phase 2

Fortified Oral Rehydration Therapy for Pediatric Diarrhea

Acute gastroenteritis
Paul A Breslin72 enrolled1 locationNCT06137014
Recruiting
Not Applicable

Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial

gastroenteritisPneumoniaUrinary Tract Infections+1 more
University of Utah2,674 enrolled14 locationsNCT05471908
Recruiting

OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages

eosinophilic esophagitisEosinophilic GastritisEosinophilic Gastrointestinal Disorders (EGIDs)+2 more
Children's Hospital Medical Center, Cincinnati1,350 enrolled19 locationsNCT02523118
Recruiting
Phase 2

PhaseⅡClinical Trial of Oral Hexavalent Reassortant Rotavirus Attenuated Live Vaccine (Vero Cells)

Rotavirus gastroenteritis
Sinovac Life Sciences Co., Ltd.400 enrolled1 locationNCT06967272
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Multiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2Rare Disorders+337 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting

Prevalence of Anemia and Growth Assessment in Acute Gastroenteritis

Acute gastroenteritis
Assiut University297 enrolled1 locationNCT06038305
Recruiting

National, Multicenter, Retrospective, Prospective Study to Evaluate Pediatric Gastrointestinal Eosinophilic Disorders

eosinophilic esophagitisEosinophilic Gastrointestinal DisordersEosinophilic Colitis+1 more
Fondazione IRCCS Policlinico San Matteo di Pavia300 enrolled1 locationNCT05219903
Recruiting

Pediatric and Ambulatory Research in Infectious Diseases

PharyngitisgastroenteritisPneumonia+4 more
Association Clinique Thérapeutique Infantile du val de Marne400,000 enrolled1 locationNCT04471493